TransMedics Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . TransMedics Group
TMDX Stock  USD 143.37  0.32  0.22%   
TransMedics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing TransMedics' valuation are provided below:
Gross Profit
341.4 M
Profit Margin
0.162
Market Capitalization
4.9 B
Enterprise Value Revenue
8.7643
Revenue
566.4 M
We have found one hundred twenty available fundamental trend indicators for TransMedics Group, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of TransMedics Group current market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 2.4 B in 2026. Enterprise Value is likely to rise to about 2.5 B in 2026

TransMedics Total Revenue

533.16 Million

Check TransMedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TransMedics' main balance sheet or income statement drivers, such as Interest Expense of 17.4 M, Selling General Administrative of 203.6 M or Operating Income of 45.3 M, as well as many indicators such as Price To Sales Ratio of 5.13, Dividend Yield of 0.0 or PTB Ratio of 8.56. TransMedics financial statements analysis is a perfect complement when working with TransMedics Valuation or Volatility modules.
  
Build AI portfolio with TransMedics Stock
Check out the analysis of TransMedics Correlation against competitors.

TransMedics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets970.9 M924.7 M265.8 M
Slightly volatile
Total Current Liabilities72.3 M68.9 M24.4 M
Slightly volatile
Other Liabilities901.6 K1.4 M1.3 M
Very volatile
Accounts Payable6 M11.8 M5.5 M
Slightly volatile
Cash406.5 M387.1 M111.6 M
Slightly volatile
Other Assets748.6 K450 K722 K
Very volatile
Long Term Debt615 M585.7 M145.4 M
Slightly volatile
Inventory56.2 M53.5 M18.5 M
Slightly volatile
Total Liabilities694.9 M661.8 M184.2 M
Slightly volatile
Total Current Assets600.4 M571.8 M189.1 M
Slightly volatile
Common Stock415 M801.8 M293.5 M
Slightly volatile
Property Plant Equipment29.4 M28 M10.2 M
Slightly volatile
Short and Long Term Debt Total625.8 M596 M149.3 M
Slightly volatile
Other Current Liabilities54.5 M51.9 M17.3 M
Slightly volatile
Property Plant And Equipment Net353.1 M336.3 M72.4 M
Slightly volatile
Non Current Assets Total370.5 M352.9 M76.7 M
Slightly volatile
Non Currrent Assets Other595.1 K637.2 K649.1 K
Very volatile
Cash And Short Term Investments406.5 M387.1 M141.5 M
Slightly volatile
Net Receivables118 M112.4 M26.6 M
Slightly volatile
Common Stock Shares Outstanding25.9 M40.5 M21.5 M
Slightly volatile
Liabilities And Stockholders Equity970.9 M924.7 M268.3 M
Slightly volatile
Non Current Liabilities Total622.5 M592.9 M160.2 M
Slightly volatile
Other Current Assets19.7 M18.7 M4.7 M
Slightly volatile
Current Deferred Revenue2.1 M2 M644 K
Slightly volatile
Common Stock Total Equity389 M587.1 M251.5 M
Slightly volatile
Long Term Debt Total31.8 M40.5 M21.8 M
Slightly volatile
Capital Surpluse158.1 M165.4 M145.8 M
Slightly volatile
Property Plant And Equipment Gross402.3 M383.1 M81.9 M
Slightly volatile
Short and Long Term Debt1.4 M1.6 M1.8 M
Slightly volatile
Net Working Capital528 M502.9 M157.3 M
Slightly volatile
Short Term Debt2.7 M2.5 M3.5 M
Pretty Stable
Deferred Long Term Liabilities2 M1.4 M2.6 M
Slightly volatile
Capital Stock592.8 M801.8 M459.8 M
Slightly volatile
Non Current Liabilities Other6.9 M7.7 M8.5 M
Slightly volatile
Intangible Assets1.8 M1.9 M2.3 M
Slightly volatile

TransMedics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative203.6 M193.9 M52.6 M
Slightly volatile
Research Development67.6 M64.4 M27.9 M
Slightly volatile
Total Operating Expenses271.2 M258.3 M81.8 M
Slightly volatile
Interest Income15.1 M14.4 M4.1 M
Slightly volatile
Depreciation And Amortization23.9 M22.7 M5.1 M
Slightly volatile
Total Revenue533.2 M507.8 M115.4 M
Slightly volatile
Gross Profit316.5 M301.4 M68.5 M
Slightly volatile
Other Operating Expenses487.9 M464.7 M129 M
Slightly volatile
Cost Of Revenue216.7 M206.4 M46.9 M
Slightly volatile
Selling And Marketing Expenses2.3 M2.4 M2.7 M
Slightly volatile
Reconciled Depreciation23.9 M22.7 M5.1 M
Slightly volatile

TransMedics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation23.9 M22.7 M5.1 M
Slightly volatile
Capital Expenditures156.7 M149.2 M37.7 M
Slightly volatile
Total Cash From Financing Activities25 M26.3 M73.2 M
Pretty Stable
End Period Cash Flow407.1 M387.7 M112.1 M
Slightly volatile
Sale Purchase Of Stock816.5 K859.5 K26.5 M
Slightly volatile
Stock Based Compensation40.1 M38.2 M9 M
Slightly volatile
Begin Period Cash Flow477.3 M454.6 M101.1 M
Slightly volatile
Other Non Cash Items5.3 M6.2 M3.3 M
Slightly volatile
Dividends Paid61.7 M58.8 M19.3 M
Slightly volatile
Change Receivables672 K756 K825.2 K
Slightly volatile
Cash And Cash Equivalents Changes1.4 M1.6 M1.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.135.431.3894
Slightly volatile
Days Sales Outstanding69.0572.782.6419
Very volatile
Stock Based Compensation To Revenue0.0580.06770.0483
Slightly volatile
Capex To Depreciation3.445.914.0497
Slightly volatile
EV To Sales5.585.8731.4474
Slightly volatile
Inventory Turnover3.643.471.4143
Slightly volatile
Days Of Inventory On Hand103109366
Slightly volatile
Payables Turnover16.4815.695.1289
Slightly volatile
Sales General And Administrative To Revenue0.420.440.8396
Slightly volatile
Research And Ddevelopement To Revenue0.140.151.4061
Slightly volatile
Capex To Revenue0.140.260.2021
Very volatile
Cash Per Share9.579.125.1628
Slightly volatile
Days Payables Outstanding22.8724.07189
Slightly volatile
Income Quality1.11.581.0427
Pretty Stable
Intangibles To Total Assets0.02060.01960.0201
Slightly volatile
Current Ratio5.667.476.6023
Slightly volatile
Receivables Turnover4.985.24.5841
Very volatile
Graham Number10.2811.5712.6259
Slightly volatile
Capex Per Share3.693.511.0545
Slightly volatile
Revenue Per Share12.5611.963.3179
Slightly volatile
Interest Debt Per Share15.1514.434.5474
Slightly volatile
Debt To Assets0.330.580.3207
Slightly volatile
Operating Cycle192202451
Slightly volatile
Days Of Payables Outstanding22.8724.07189
Slightly volatile
Ebt Per Ebit1.181.11.0689
Pretty Stable
Quick Ratio5.056.775.8814
Slightly volatile
Net Income Per E B T1.091.141.0105
Slightly volatile
Cash Ratio2.625.062.552
Slightly volatile
Cash Conversion Cycle340178272
Pretty Stable
Days Of Inventory Outstanding103109366
Slightly volatile
Days Of Sales Outstanding69.0572.782.6419
Very volatile
Fixed Asset Turnover1.651.743.2013
Slightly volatile
Debt Ratio0.330.580.3207
Slightly volatile
Price Sales Ratio5.135.431.3894
Slightly volatile
Asset Turnover0.520.490.2424
Slightly volatile
Gross Profit Margin0.420.530.3763
Slightly volatile

TransMedics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.4 B2.3 B941.4 M
Slightly volatile
Enterprise Value2.5 B2.4 B963.4 M
Slightly volatile

TransMedics Fundamental Market Drivers

Forward Price Earnings59.8802
Cash And Short Term Investments336.6 M

TransMedics Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About TransMedics Financial Statements

TransMedics investors use historical fundamental indicators, such as TransMedics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TransMedics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue2 M2.1 M
Total Revenue507.8 M533.2 M
Cost Of Revenue206.4 M216.7 M
Stock Based Compensation To Revenue 0.07  0.06 
Sales General And Administrative To Revenue 0.44  0.42 
Research And Ddevelopement To Revenue 0.15  0.14 
Capex To Revenue 0.26  0.14 
Revenue Per Share 11.96  12.56 
Ebit Per Revenue 0.08  0.08 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY